Retinopathy of prematurity
- PMID: 17332988
- DOI: 10.1007/s10456-007-9066-0
Retinopathy of prematurity
Abstract
Retinopathy of prematurity (ROP) is a common blinding disease in children in the developed world despite current treatment, and is becoming increasingly prevalent in the developing world. ROP progresses in two phases. The first phase begins with delayed retinal vascular growth after birth and partial regression of existing vessels, followed by a second phase of hypoxia-induced pathological vessel growth. Two major risk factors of ROP are the use of oxygen and a decreased gestation period. Excessive oxygen contributes to ROP through regulation of vascular endothelial growth factor (VEGF). Suppression of VEGF by oxygen in phase I of ROP inhibits normal vessel growth, whereas elevated levels of VEGF induced by hypoxia in phase II of ROP precipitate pathological vessel proliferation. Insulin-like growth factor 1 (IGF-1) is a critical non-oxygen-regulated factor in ROP. We have found that serum levels of IGF-1 in premature babies directly correlate with the severity of clinical ROP. IGF-1 acts indirectly as a permissive factor by allowing maximal VEGF stimulation of vessel growth. Lack of IGF-1 in preterm infants prevents normal retinal vascular growth in phase I of ROP, despite the presence of VEGF. As infants mature, rising levels of IGF-1 in phase II of ROP allows VEGF stimulated pathological neovascularization. These findings suggest that restoration of IGF-1 to normal levels might be useful in preventing ROP in preterm infants.
Similar articles
-
Pathogenesis of retinopathy of prematurity.Growth Horm IGF Res. 2004 Jun;14 Suppl A:S140-4. doi: 10.1016/j.ghir.2004.03.030. Growth Horm IGF Res. 2004. PMID: 15135797 Review.
-
Pathogenesis of retinopathy of prematurity.Semin Neonatol. 2003 Dec;8(6):469-73. doi: 10.1016/S1084-2756(03)00119-2. Semin Neonatol. 2003. PMID: 15001119 Review.
-
[Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].Klin Oczna. 2009;111(10-12):302-6. Klin Oczna. 2009. PMID: 20169883 Polish.
-
The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.Mol Vis. 2004 Jan 21;10:43-50. Mol Vis. 2004. PMID: 14758338
-
IGF-1 and retinopathy of prematurity in the preterm infant.Biol Neonate. 2005;88(3):237-44. doi: 10.1159/000087587. Biol Neonate. 2005. PMID: 16210846 Review.
Cited by
-
Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options.Int J Ophthalmol. 2013 Apr 18;6(2):228-36. doi: 10.3980/j.issn.2222-3959.2013.02.23. Print 2013. Int J Ophthalmol. 2013. PMID: 23641347 Free PMC article.
-
Choroidal measurements in decision making for retinopathy of prematurity: a decision tree analysis.Int J Retina Vitreous. 2024 Jan 11;10(1):4. doi: 10.1186/s40942-023-00520-6. Int J Retina Vitreous. 2024. PMID: 38212793 Free PMC article.
-
Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis.Elife. 2022 Dec 1;11:e73105. doi: 10.7554/eLife.73105. Elife. 2022. PMID: 36454214 Free PMC article.
-
Neonatal hyperoxia in mice triggers long-term cognitive deficits via impairments in cerebrovascular function and neurogenesis.J Clin Invest. 2022 Nov 15;132(22):e146095. doi: 10.1172/JCI146095. J Clin Invest. 2022. PMID: 36136598 Free PMC article.
-
Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen.J Clin Med. 2023 Feb 3;12(3):1228. doi: 10.3390/jcm12031228. J Clin Med. 2023. PMID: 36769876 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous